Literature DB >> 12387906

The dog as model for chemotherapy of the Chagas' disease.

Paulo Marcos da Matta Guedes1, Vanja Maria Veloso, Washington Luiz Tafuri, Lúcia Maria da Cunha Galvão, Cláudia Martins Carneiro, Marta de Lana, Egler Chiari, Killarney Ataide Soares, Maria Terezinha Bahia.   

Abstract

In the present study, we investigated the role of dogs as experimental models for acute and chronic phases of Chagas' disease, before and after therapeutic treatments. Dogs were infected with Trypanosoma cruzi strains of different susceptibilities to benznidazole (Bz) and treated with the same therapeutic scheme as used for human chagasic. The treatment with Bz was able to prevent death and induced parasitological cure in 62.5% (acute phase) and 38.7% (chronic recent phase) of the tested animals. These results were similar to those reported in clinical trials for treated human patients (cured and uncured) in both phases of the disease. We also showed that parasitologic and serologic tests for monitoring the cure were similar to those obtained for human trials. In addition, Polymerase chain reaction showed the highest sensitivity when compared with hemoculture as an indicator of parasite clearance. In conclusion, the proposed experimental model should be relevant for chemotherapy studies for the control of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387906     DOI: 10.1016/s0001-706x(02)00139-0

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Advances in imaging of animal models of Chagas disease.

Authors:  Linda A Jelicks; Herbert B Tanowitz
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 2.  Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.

Authors:  Cristina Fonseca-Berzal; Vicente J Arán; José A Escario; Alicia Gómez-Barrio
Journal:  Parasitol Res       Date:  2018-09-19       Impact factor: 2.289

3.  Chemokine receptor 7 (CCR7)-expression and IFNγ production define vaccine-specific canine T-cell subsets.

Authors:  Ashley N Hartley; Rick L Tarleton
Journal:  Vet Immunol Immunopathol       Date:  2015-02-07       Impact factor: 2.046

Review 4.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.

Authors:  Rodrigo Moreira da Silva; Líliam Teixeira Oliveira; Neila Márcia Silva Barcellos; Jacqueline de Souza; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

6.  Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.

Authors:  Paulo Marcos da Matta Guedes; Julio A Urbina; Marta de Lana; Luis C C Afonso; Vanja M Veloso; Washington L Tafuri; George L L Machado-Coelho; Egler Chiari; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

Authors:  Lívia de Figueiredo Diniz; Ivo Santana Caldas; Paulo Marcos da Matta Guedes; Geovam Crepalde; Marta de Lana; Cláudia Martins Carneiro; André Talvani; Julio Alberto Urbina; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 8.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

9.  Bottlenecks in domestic animal populations can facilitate the emergence of Trypanosoma cruzi, the aetiological agent of Chagas disease.

Authors:  Michael Z Levy; Aaron Tustin; Ricardo Castillo-Neyra; Tarub S Mabud; Katelyn Levy; Corentin M Barbu; Victor R Quispe-Machaca; Jenny Ancca-Juarez; Katty Borrini-Mayori; Cesar Naquira-Velarde; Richard S Ostfeld
Journal:  Proc Biol Sci       Date:  2015-07-07       Impact factor: 5.349

10.  Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

Authors:  Ivo Santana Caldas; André Talvani; Sérgio Caldas; Cláudia Martins Carneiro; Marta de Lana; Paulo Marcos da Matta Guedes; Maria Terezinha Bahia
Journal:  Parasitol Res       Date:  2008-05-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.